ABSI - Rasio rega marang prakiraan pendapatan Absci
Absci utilizes an AI platform for accelerated drug synthesis, leveraging support from leading pharma behemoths. The expected P/S valuation reflects market expectations, where 1000.40 determines this parameter level. Absci is reducing R&D expenditures in immuno-oncology, monetizing its breakthrough developments through B2B partnerships in the digital antibody design segment.
Rincian analitis perusahaan Absci Bio (ABSI)
- rega saiki lan proyeksi nilai saham:
- statistik kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Absci|ABSI - Rasio silihan jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Absci|ABSI - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Absci Bio|ABSI - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Absci|Rasio cepet absci.com
- rincian asil keuangan lan kelipatan valuasi:
ABSI - Bathi perusahaan|Proyeksi bathi mangsa ngarep Absci|ABSI - Pangali P/E|Pangali Forward P/E Absci Corp.|ABSI - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Absci Bio|ABSI - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Absci|ABSI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan absci.com|ABSI - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Absci
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:ABSI (Absci Corporation)
Valuing Absci (ABSI) assets requires accounting for the synergy between AI-driven antibody design and ESG optimization, which reduces reagent costs. By analyzing the expected P/S ratio, an investor can observe the dynamic business value relative to projected revenue, enabling a real-time assessment of the cloud platform's scaling potential against the risks of overcapitalization or frozen invested capital.
Pesaing Absci (ABSI)
Multiplikator Forward P/S VEEV (Veeva)|Doximity Inc - Rasio rega marang prakiraan pendapatan|HQY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Waystar Corp WAY|CRVL: Multiplikator Forward P/S|PRVA - Rasio kapitalisasi marang dodolan sing dikarepake|HURN (Huron) - Multiplikator Forward P/S|Certara Inc (CERT) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan OMCL (Omnicell Corp)|Rasio rega marang pendapatan sing dikarepake GDRX|Schrodinger, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PHR|OMDA - Rasio rega marang prakiraan pendapatan|Evolent Health Inc (EVH) - Multiplikator forward rega marang pendapatan|HSTM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Definitive Corp (DH)|CCSI (Consensus Cloud Solutions) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AGL (agilonhealth.com)|Multiplikator Forward P/S SY|Multiplikator Forward P/S NRC Health (NRC)|Multiplikator Forward P/S SPOK (Spok Corp)|OptimizeRx Inc. - Rasio rega marang prakiraan pendapatan|TBRG - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake simulations-plus.com SLP|SOPH: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Health Catalyst Inc.|CCLD (CareCloud Inc.) - Multiplikator Forward P/S|Research Solutions Inc. (RSSS) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S DLHC|Multiplikator Forward P/S onemednet.com (ONMD)|Multiplikator Forward P/S SCNX (Scienture)|Healthcare Triangle Inc - Rasio rega marang prakiraan pendapatan|ISPC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Bullfrog AI Holdings BFRG|WORX: Multiplikator Forward P/S|MSPR - Rasio kapitalisasi marang dodolan sing dikarepake|ICCT (iCoreConnect, Inc.) - Multiplikator Forward P/S|TRxADE HEALTH Inc (MEDS) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ORGS (Orgenesis Corp)|Rasio rega marang pendapatan sing dikarepake RCM|Sharecare, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan STRM|SYRA - Rasio rega marang prakiraan pendapatan|Apollo Medical Holdings (AMEH) - Multiplikator forward rega marang pendapatan|MODN: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NextGen Healthcare Corp (NXGN)
